疾病2Vec:通过疾病嵌入树编码阿尔茨海默氏症的进展
Lu Zhang1, Li Wang2, Tianming Liu3
1Department of Computer Science and Engineering, The University of Texas at Arlington, Arlington, TX, USA.
Pharmacological research
|December 10, 2023
概括
这项研究介绍了Disease2Vec,这是阿尔茨海默病 (AD) 进展建模的新框架. 它准确地预测患者在连续阶段的病情,提供比传统分类方法更细致的理解.
科学领域:
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
- 医疗信息学 医疗信息学
背景情况:
- 传统的阿尔茨海默病 (AD) 预测模型往往忽视了疾病进展的持续性质.
- 现有的方法主要侧重于二进制或多类分类,未能捕捉临床阶段之间的微妙过渡.
- 以前的AD进展模型主要旨在订购生物标志物,而不是在连续范围内预测个体患者的状态.
研究的目的:
- 开发一种新的基于学习的嵌入框架,用于建模阿尔茨海默氏症 (AD) 进展.
- 在连续的潜伏空间中表示AD临床阶段之间的内在关系.
- 为了能够准确地预测整个AD发展的全谱的个体患者的状态.
主要方法:
- 开发了Disease2Vec,这是一个基于学习的嵌入框架,用于编码AD临床阶段之间的关系.
- 创建了一个疾病嵌入树 (DETree) 来表示AD进展作为连续的轨迹.
- 利用DETree预测个体患者的临床状况,通过将他们投射到连续轨迹上.
主要成果:
- 疾病2Vec框架及其生成的DETree有效地代表了AD的进展.
- 该模型能够在五个细粒度临床组中高效准确地预测患者状况.
- 该方法通过分析患者在连续进展轨迹中的位置来提供更丰富的状态信息.
结论:
- 开发的疾病嵌入框架 (Disease2Vec) 在建模阿尔茨海默氏症 (AD) 进展方面取得了重大进展.
- DETree提供了一个连续的轨迹,可以更准确,更详细地预测个体患者的病情.
- 这种新的方法解决了在持续AD发展的频谱中预测患者状况的研究不足的问题.
更多相关视频
04:41Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
19.0K
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
10.3K
相关概念视频
01:26Alzheimer's Disease: Overview
492
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
492
01:22Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
03:03Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K
01:30Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
01:37Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K